Homogeneous binuclear transition metal single atom catalyst and preparation method and application thereof
By using homogeneous dual-core transition metal single-atom catalysts, the synergistic effect of the active components of the dual-core transition metal are solved, and the catalytic activity and stability of single-atom catalysts are achieved efficient advanced oxidative antibiotic degradation and reduced environmental pollution and application costs.
Patent Information
- Application Number
- CN202211594101.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-13
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2042-12-13
AI Technical Summary
Existing single-atom catalysts have limitations in catalytic activity and stability, especially in the field of advanced oxidative antibiotics, which face problems such as small pH range, poor stability, and uneven active sites.
The homogeneous dual-core transition metal single-atom catalyst is used to improve catalytic activity through the synergistic effect of the active components of the dual-core transition metal. The catalyst consists of diatomic active components, active additives and carriers with the same nucleus. The active components account for 0.1% to 5% of the total mass of the catalyst, and the atomic ratio of the active additive to the active component is 0.1~2: 1.
Through the synergistic effect of the binuclear metal component, the load limit and inherent activity limit of single-atom catalysts are broken, the catalytic activity is significantly improved, the stability and universality of the catalyst are enhanced, and environmental pollution and application costs are reduced.
Smart Images

Figure CN115970704B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of synthesis and application of new material catalysts, and specifically relates to a homogeneous binuclear transition metal single atom catalyst, and also relates to a preparation method and application of the catalyst. Background Art
[0002] Antibiotics can kill bacteria, fight infection, and save lives, but improper use can lead to bacterial resistance. Traditional technology uses the Fenton method to degrade antibiotics discharged into the water environment. Fenton reagent refers to Fe 2+ / H2O2 system, Fe 2+ As a reaction catalyst, H2O2 is activated by the catalyst to produce ·OH, which plays an oxidative role, oxidizing and decomposing organic pollutants and antibiotics in the water into small molecules without pollution, or even CO2. At present, a series of advanced oxidation technologies have been derived based on this to degrade antibiotics, mainly using the strong oxidizing free radicals produced in the reaction as the main oxidant to oxidize and decompose the oxidation of organic pollutants in mineralized water. The new persulfate advanced oxidation technology has the characteristics of strong oxidizing ability, the redox potential of ·OH is 1.8~2.7V, and the sulfate free radicals (·SO 4- ) has a redox potential of 2.5 to 3.1 V. ·SO 4- The reaction speed is fast, and the oxidation rate constant for most organic substances reaches 106~109M -1 s -1 , wide range of applications, mild reaction conditions, and high mineralization rate for organic pollutants.
[0003] Since then, more efficient and environmentally friendly transition metal (Mn, Fe, Co, Cu, etc.) nanocatalysts have been continuously developed, but this type of catalyst faces severe challenges such as a small applicable pH range, poor stability, non-uniform active sites, and large metal dosage. Compared with traditional nanocatalysts, single atom catalysts (SACs) have many advantages such as relatively uniform active sites, 100% atomic utilization efficiency, and adjustable coordination environment, which can further improve the activity and stability of nanocatalysts. However, the development of SACs still encounters challenges: on the one hand, the metal loading of SACs is usually limited to 1-2wt%, otherwise, due to the high surface energy, it is easy to cause metal aggregation. Therefore, although SACs have high atomic efficiency, the overall catalytic activity is not satisfactory. On the other hand, SACs are isolated active sites, usually containing a central metal atom and surrounding non-metal atoms such as C and N. Therefore, despite great efforts in structural engineering, there is little hope that SACs can break their inherent activity limit. In addition, it is difficult for SACs to achieve optimal catalytic effects in complex catalytic reactions involving multiple intermediates. Summary of the invention
[0004] The first object of the present invention is to provide a homogeneous binuclear transition metal single atom catalyst, and to improve the catalytic activity of the single atom catalyst by the synergistic effect of the binuclear transition metal active component.
[0005] The second object of the present invention is to provide a method for preparing the above binuclear transition metal single atom catalyst.
[0006] The third object of the present invention is to provide the application of the above binuclear transition metal single atom catalyst in the field of advanced oxidation antibiotics.
[0007] The first technical solution adopted by the present invention is a homogeneous binuclear transition metal single atom catalyst, which is composed of a homogeneous binuclear diatomic active component, an active auxiliary agent and a carrier. The mass fraction of the active component in the total mass of the catalyst is 0.1wt.% to 5wt.%, and the atomic ratio of the active auxiliary agent to the active component is 0.1 to 2:1.
[0008] The first technical solution adopted by the present invention is also characterized in that:
[0009] The homonuclear diatomic active components are any one or more of binuclear Fe, Co, Mn, Ni and Cu.
[0010] The active auxiliary agent is any one or more of the non-metallic elements B, F and Se.
[0011] The carrier is any one of tungsten oxide, cobalt oxide, molybdenum oxide or rhenium oxide.
[0012] The second technical solution adopted by the present invention is a method for preparing a binuclear transition metal single atom catalyst, which is specifically implemented according to the following steps:
[0013] Step 1, dissolving one of tungsten chloride, molybdenum chloride, cobalt chloride and rhenium chloride in one or more of water, ethanol, ethylene glycol or glycerol, hydrothermal treatment for 24 to 48 hours, filtering, washing and drying to obtain tungsten oxide, cobalt oxide, molybdenum oxide and rhenium oxide as carriers;
[0014] Step 2, selecting an organic precursor of a binuclear transition metal and dissolving it in a solvent to prepare an active component precursor solution, adding the carrier obtained in step 1 to the active component precursor solution, and simultaneously adding one or more of boric acid, hydrofluoric acid, and selenic acid, grinding the solution in a mortar at room temperature until the solution is shade-dried, and drying in an oven at 100° C. to 150° C. to obtain a powder;
[0015] Step 3, grinding the powder obtained in step 2 in a mortar for 10 to 20 minutes, and then calcining in a tubular furnace for 1 to 3 hours to obtain a binuclear transition metal single atom catalyst.
[0016] The second technical solution adopted by the present invention is also characterized in that:
[0017] In step 1, the drying method is any one of conventional drying, vacuum drying and freeze drying.
[0018] In step 2, the binuclear transition metal is any one or more of binuclear Fe, Co, Mn, Ni, and Cu, and the organic precursor of the binuclear transition metal is a binuclear phthalocyanine compound.
[0019] In step 2, the solvent is any one of ethanol, acetone, n-propanol, isopropanol, and ethyl acetate.
[0020] In step 3, the calcination atmosphere is any one of air, nitrogen, and hydrogen, or a mixture of two gases, and the calcination temperature is 200 to 800°C.
[0021] The third technical solution adopted by the present invention is the application of homogeneous binuclear transition metal single atom catalyst in the field of advanced oxidation antibiotics.
[0022] The beneficial effects of the present invention are:
[0023] (1) The homogeneous binuclear transition metal single atom catalyst of the present invention breaks through the loading limit and inherent activity limit of the single atom catalyst through the synergistic effect of the binuclear metal components, and the catalyst structure is relatively uniform, which not only significantly improves the catalytic activity, but also facilitates the clarification of the structure-activity relationship;
[0024] (2) The preparation method of the homogeneous binuclear transition metal single atom catalyst of the present invention has a simple process and the prepared catalyst has excellent universality and anti-interference ability;
[0025] (3) The homogeneous binuclear transition metal single atom catalyst of the present invention is applied to the advanced oxidation antibiotic reaction of traditional homogeneous catalysis, which greatly improves the catalytic activity, reduces environmental pollution and application cost, and is a sustainable development path. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The degradation efficiency diagram of different carriers and mononuclear and binuclear single-atom catalysts prepared in Example 1 of the present invention;
[0027] Figure 2 is the Co2 / WO in Example 1 of the present invention x Synchrotron radiation diagram;
[0028] Figure 3 The Co2 / WO with additives added in Example 2 of the present invention x Degradation efficiency diagram;
[0029] Figure 4 This is a graph showing the degradation efficiency of different antibiotics in Example 3 of the present invention;
[0030] Figure 5 This is a graph of degradation efficiency at different pH values in Example 4 of the present invention. DETAILED DESCRIPTION
[0031] The present invention will be further described below through the accompanying drawings and specific embodiments.
[0032] The present invention provides a homogeneous binuclear transition metal single-atom catalyst, which consists of a homogeneous binuclear binuclear active component, an active auxiliary agent and a carrier. The mass fraction of the active component in the total mass of the catalyst is 0.1wt.% to 5wt.%, and the atomic ratio of the active auxiliary agent to the active component is 0.1 to 2:1.
[0033] Among them, the homonuclear diatomic active components are any one or more of binuclear Fe, Co, Mn, Ni, and Cu;
[0034] The active additive is any one or more of the non-metallic elements B, F, and Se;
[0035] The carrier is any one of tungsten oxide, cobalt oxide, molybdenum oxide or rhenium oxide.
[0036] The present invention also provides a method for preparing a homogeneous binuclear transition metal single atom catalyst, which is specifically implemented according to the following steps:
[0037] Step 1, dissolving one of tungsten chloride, molybdenum chloride, cobalt chloride and rhenium chloride in one or more of water, ethanol, ethylene glycol or glycerol, hydrothermal treatment for 24 to 48 hours, filtering, washing and drying to obtain tungsten oxide, cobalt oxide, molybdenum oxide and rhenium oxide as carriers;
[0038] The drying method is any one of conventional drying, vacuum drying and freeze drying;
[0039] Step 2, selecting an organic precursor of a binuclear transition metal and dissolving it in a solvent to prepare an active component precursor solution, adding the carrier obtained in step 1 to the active component precursor solution, and simultaneously adding one or more of boric acid, hydrofluoric acid, and selenic acid, grinding the solution in a mortar at room temperature until the solution is shade-dried, and drying in an oven at 100° C. to 150° C. to obtain a powder;
[0040] The binuclear transition metal is any one or more of binuclear Fe, Co, Mn, Ni, and Cu, and the organic precursor of the binuclear transition metal is a binuclear phthalocyanine compound;
[0041] The solvent is any one of ethanol, acetone, n-propanol, isopropanol, and ethyl acetate;
[0042] Step 3, continue grinding the powder obtained in step 2 in a mortar for 10 minutes to 20 minutes, and then calcine in a tubular furnace for 1 hour to 3 hours. The calcination atmosphere is any one of air, nitrogen, and hydrogen or a mixture of two gases. The calcination temperature is 200 to 800°C to obtain a binuclear transition metal single atom catalyst.
[0043] The present invention also provides an application of a homogeneous binuclear transition metal single atom catalyst in the field of advanced oxidation antibiotics. The method for advanced oxidation antibiotics using the binuclear transition metal single atom catalyst of the present invention is as follows: 50 mL of antibiotics with a concentration of 10 to 20 mg / L is used as a raw material liquid, and the solvent is water; the amount of the catalyst is 1 to 5 mg; the amount of the oxidant is 10 mg to 20 mg; the above raw materials are stirred evenly at a stirring rate of 300 to 700 rpm;
[0044] The antibiotics used were any one of tetracycline, tetracycline hydrochloride, ciprofloxacin, and levofloxacin.
[0045] The oxidant is any one of hydrogen peroxide, peroxymonosulfate (PMS) and peroxydisulfate (PDS).
[0046] Example 1
[0047] Step 1: Dissolve 1 g of tungsten hexachloride in 33 mL of ethanol, heat for 24 h, filter, wash the solid three times with ethanol and water, freeze-dry for 12 h, and obtain a tungsten oxide carrier, denoted as WO x ;
[0048] Step 2: dissolving binuclear cobalt phthalocyanine in ethyl acetate to prepare a binuclear cobalt phthalocyanine organic solution with a Co concentration of 0.1 wt.%. x Add to 10 mL of organic solution of binuclear cobalt phthalocyanine precursor, grind in a mortar at room temperature until the solution is dry, and dry in an oven;
[0049] Step 3, after grinding in a mortar for 15 minutes, calcining at 400° C. for 1 hour in a tubular furnace under a nitrogen atmosphere to obtain a binuclear transition metal single atom catalyst.
[0050] In this embodiment, different carriers are used to replace the tungsten oxide carrier, and finally a binuclear single-atom catalyst in which the binuclear transition metal accounts for 1% of the total mass of the catalyst is obtained. The different catalysts are: Co2 / WO x 、Co2 / MoO x 、Co2 / ReO x This example also uses mononuclear cobalt phthalocyanine instead of binuclear cobalt phthalocyanine to prepare a single-component transition metal single-atom catalyst, and finally obtains a single-atom catalyst in which the transition metal accounts for 1% of the total mass of the catalyst. The catalyst is: Co1 / WO x. Take 3.0 mg of each of the above catalysts and add them to 50 mL of 15 mg / L levofloxacin solution. Stir continuously for 40 min at 400 rpm. The absorbance of the levofloxacin solution is detected by UV-visible spectroscopy and recorded as C0, and the time is recorded as t0. Add 15 mg of potassium permonosulfate and continue stirring. Take samples for analysis every 10 min and record the absorbance of the solution as C and the time as t. After 40 min, if Figure 1 As shown in the figure, the degradation rates of levofloxacin solution using different catalysts were 99%, 95%, 93% and 43% respectively. x The binuclear single-atom catalyst was characterized by synchrotron radiation, and the results obtained are as follows Figure 2 shown.
[0051] Example 1 shows that the present invention uses binuclear transition metal single atom active components, and the oxidative degradation activity is greatly improved compared with the mononuclear transition metal single atom active components. After 40 minutes, the levofloxacin solution is oxidatively degraded to 99%.
[0052] Example 2
[0053] Based on Example 1, 1 g of WO x Add to 10mL of the organic solution of binuclear cobalt phthalocyanine precursor, and add boric acid, hydrofluoric acid, selenic acid and other additives at the same time. The atomic ratio of active additive to active component is 1:1. Grind in a mortar at room temperature until the solution is shade-dried, and dry in an oven. Grind in a mortar for 15 minutes, and then calcine at 400°C in a tubular furnace under nitrogen atmosphere for 1 hour. Take 3.0 mg of each binuclear single-atom catalyst modified by the above different additives and add them to 50mL of 15mg / L levofloxacin solution. Stir continuously for 40 minutes at a speed of 400rpm. At this time, the absorbance of the levofloxacin solution is detected by ultraviolet-visible spectroscopy, recorded as C0, and the time is recorded as t0. Add 15mg of potassium permonosulfate, continue stirring, take samples for analysis every 10 minutes, record the absorbance of the solution as C, and the time is t. After 30 minutes, if Figure 3 As shown, the degradation rate of levofloxacin solution by binuclear single atom catalysts modified with different additives reached 99%.
[0054] Example 3
[0055] Take 3.0 mg of Co2 / WO prepared in Example 1 above xThe binuclear single-atom catalyst was added to 50 mL of different antibiotic solutions with a concentration of 15 mg / L, including tetracycline solution, tetracycline hydrochloride solution, ciprofloxacin solution, and levofloxacin solution. After stirring for 40 minutes at a speed of 400 rpm, the absorbance of the solution was detected by ultraviolet-visible spectroscopy, recorded as C0, and the time was recorded as t0. 15 mg of potassium permonosulfate was added, and stirring was continued. Samples were taken every 10 minutes for analysis and detection, and the absorbance of the solution was recorded as C and the time was t. After 40 minutes, if Figure 4 As shown, the degradation rates of different antibiotics using the same catalyst are 99%, 98%, 93% and 99% respectively. The above Example 3 shows that the binuclear single atom catalyst has universal applicability to the advanced oxidation degradation of antibiotics.
[0056] Example 4
[0057] Take seven groups of 3 mg of Co2 / WO prepared in Example 1 above x The binuclear single-atom catalyst was added to 50 mL of 15 mg / L levofloxacin solution, and the solution was adjusted to a certain pH value, and the pH values were adjusted to 1, 3, 5, 7, 9, 11, and 13 respectively. After stirring for 1 hour at a speed of 400 rpm, the absorbance of the tetracycline solution was detected by UV-visible spectroscopy, recorded as C0, and the time was recorded as t0. 15 mg of potassium permonosulfate was added, and stirring was continued. Samples were taken every 10 minutes for analysis and detection. The absorbance of the solution was recorded as C, and the time was t. Figure 5 As shown, the degradation rates of levofloxacin solution at different pH values for 40 min are 99%, 98%, 99%, 99%, 97%, 91%, and 88%. The results of Example 4 above show that the process has a broad pH window, is beneficial to the stability of the catalyst, reduces environmental pollution, and has good industrial prospects.
[0058] Example 5
[0059] Step 1: Dissolve 1 g of tungsten hexachloride in 33 mL of ethanol, heat for 36 h, filter, wash the solid three times with ethylene glycol and water, and dry it for 12 h to obtain a tungsten oxide carrier, which is recorded as WO. x ;
[0060] Step 2: Dissolve binuclear copper phthalocyanine in isopropanol to prepare a binuclear copper phthalocyanine organic solution with a Cu concentration of 0.1 wt.%. x Add to 10mL of organic solution of binuclear copper phthalocyanine precursor, add boric acid, hydrofluoric acid, selenic acid and other additives respectively, the atomic ratio of active additive to active component is 2:1, grind in a mortar at room temperature until the solution is shade-dried, and dry in an oven;
[0061] Step 3, after grinding in a mortar for 20 minutes, calcining at 800° C. for 2 hours in a tubular furnace under a nitrogen atmosphere to obtain a binuclear transition metal single atom catalyst.
[0062] In this embodiment, different carriers are used to replace the tungsten oxide carrier, and finally a binuclear single-atom catalyst in which the binuclear transition metal accounts for 1% of the total mass of the catalyst is obtained. The different catalysts are: Cu2 / WO x 、Cu2 / MoO x 、Cu2 / ReO x .
[0063] The method for advanced oxidation of antibiotics using the binuclear transition metal single atom catalyst of the present invention is as follows: 50 mL of tetracycline hydrochloride with a concentration of 20 mg / L is used as the raw material liquid, the solvent is water, the amount of the catalyst is 5 mg, the temperature is room temperature, and the stirring rate is 700 rpm.
[0064] Example 6
[0065] Step 1: Dissolve 1 g of tungsten hexachloride in 33 mL of ethanol, heat for 48 h, filter, wash the solid three times with ethylene glycol and water, and vacuum dry for 12 h to obtain a tungsten oxide carrier, denoted as WO x ;
[0066] Step 2: Dissolve binuclear manganese phthalocyanine in isopropanol to prepare a binuclear manganese phthalocyanine organic solution with a Mn concentration of 0.1 wt.%. x Add to 10mL of organic solution of binuclear manganese phthalocyanine precursor, add boric acid, hydrofluoric acid, selenic acid and other additives respectively, the atomic ratio of active additive to active component is 0.1:1, grind in a mortar at room temperature until the solution is shade-dried, and dry in an oven;
[0067] Step 3, after grinding in a mortar for 10 minutes, calcining at 200° C. for 3 hours in a tubular furnace under a nitrogen atmosphere to obtain a binuclear transition metal single atom catalyst.
[0068] In this embodiment, different carriers are used to replace the tungsten oxide carrier, and finally a binuclear single-atom catalyst in which the binuclear transition metal accounts for 1% of the total mass of the catalyst is obtained. The different catalysts are: Mn2 / WO x 、Mn2 / MoO x 、Mn2 / ReO x .
[0069] The method for using the binuclear transition metal single atom catalyst of the present invention to carry out advanced oxidation of antibiotics is as follows: 50 mL of ciprofloxacin with a concentration of 10 mg / L is used as a raw material liquid, the solvent is water, the amount of catalyst is 1 mg, the temperature is room temperature, and the stirring rate is 300 rpm.
[0070] A binuclear transition metal single-atom catalyst of the present invention is a catalyst using a binuclear transition metal as an active component, any one or more of non-metallic elements B, F, and Se as an active auxiliary agent, and any one of tungsten oxide, cobalt oxide, molybdenum oxide, or rhenium oxide rich in oxygen defects as a carrier. Due to the synergistic effect of binuclear single-atom sites, the binuclear metal catalyst of the present invention exhibits excellent catalytic reaction performance compared to single-metal component single-atom catalysts, and has excellent universality and anti-interference ability, and has broad commercial application prospects. Applying it to the advanced oxidation antibiotic reaction of traditional homogeneous catalysis can greatly improve the catalytic activity, reduce environmental pollution and application costs, and is a sustainable development path.
Claims
1. A homogeneous binuclear transition metal single atom catalyst, characterized in that: The catalyst is composed of a homogeneous binuclear diatomic active component, an active auxiliary agent and a carrier, wherein the mass fraction of the active component in the total mass of the catalyst is 0.1wt.%~5wt.%, and the atomic ratio of the active auxiliary agent to the active component is (0.1~2):1; The homogeneous binuclear diatomic active component is any one or more of binuclear Fe, binuclear Co, binuclear Mn, binuclear Ni, and binuclear Cu; The active auxiliary agent is Se; The carrier is any one of tungsten oxide, cobalt oxide, molybdenum oxide or rhenium oxide; The preparation method of the catalyst is specifically implemented according to the following steps: Step 1, dissolving one of tungsten chloride, cobalt chloride, molybdenum chloride and rhenium chloride in one or more of water, ethanol, ethylene glycol or glycerol, hydrothermal treatment for 24 to 48 hours, filtering, washing and drying to obtain one of tungsten oxide, cobalt oxide, molybdenum oxide and rhenium oxide as a carrier; Step 2, dissolving an organic precursor of a binuclear transition metal in a solvent to prepare an active component precursor solution, adding the carrier obtained in step 1 to the active component precursor solution, adding selenic acid, grinding the solution in a mortar at room temperature until the solution is shade-dried, and drying in an oven at 100° C. to 150° C. to obtain a powder; In step 2, the binuclear transition metal is any one or more of binuclear Fe, binuclear Co, binuclear Mn, binuclear Ni, and binuclear Cu, and the organic precursor of the binuclear transition metal is a binuclear transition metal phthalocyanine compound; Step 3, grinding the powder obtained in step 2 in a mortar for 10 min to 20 min, and then calcining in a tube furnace for 1 h to 3 h to obtain a homogeneous binuclear transition metal single atom catalyst; In step 3, the calcination atmosphere is any one of air, nitrogen, and hydrogen or a mixture of two gases, and the calcination temperature is 200-800°C.
2. The method for preparing a homogeneous binuclear transition metal single atom catalyst according to claim 1, characterized in that: Follow the steps below to implement it: Step 1, dissolving one of tungsten chloride, cobalt chloride, molybdenum chloride and rhenium chloride in one or more of water, ethanol, ethylene glycol or glycerol, hydrothermal treatment for 24 to 48 hours, filtering, washing and drying to obtain one of tungsten oxide, cobalt oxide, molybdenum oxide and rhenium oxide as a carrier; Step 2, dissolving an organic precursor of a binuclear transition metal in a solvent to prepare an active component precursor solution, adding the carrier obtained in step 1 to the active component precursor solution, adding selenic acid, grinding the solution in a mortar at room temperature until the solution is shade-dried, and drying in an oven at 100° C. to 150° C. to obtain a powder; In step 2, the binuclear transition metal is any one or more of binuclear Fe, binuclear Co, binuclear Mn, binuclear Ni, and binuclear Cu, and the organic precursor of the binuclear transition metal is a binuclear transition metal phthalocyanine compound; Step 3, grinding the powder obtained in step 2 in a mortar for 10 min to 20 min, and then calcining in a tube furnace for 1 h to 3 h to obtain a homogeneous binuclear transition metal single atom catalyst; In step 3, the calcination atmosphere is any one of air, nitrogen, and hydrogen or a mixture of two gases, and the calcination temperature is 200-800°C.
3. The method for preparing a homogeneous binuclear transition metal single atom catalyst according to claim 2, characterized in that: In step 1, the drying method is any one of conventional drying, vacuum drying and freeze drying.
4. The method for preparing a homogeneous binuclear transition metal single atom catalyst according to claim 2, characterized in that: In step 2, the solvent is any one of ethanol, acetone, n-propanol, isopropanol, and ethyl acetate.
5. Application of the homogenous binuclear transition metal single atom catalyst according to claim 1 in the field of advanced oxidation antibiotics, characterized in that: The antibiotics were either ciprofloxacin or levofloxacin.
Citation Information
Patent Citations
Preparation method of graphene embedded with monodispersed metal atoms
CN104925784A
Heteroatom-doped transition metal monatomic catalyst, and preparation method and application thereof
CN113549935A
Transition metal monatomic active catalyst as well as preparation method and application thereof
CN113600170A
Heterogeneous monatomic catalyst as well as preparation method and application method thereof
CN114471600A
Preparation method and application of bimetal monatomic loaded BCN aerogel catalyst
CN115155647A
